Summary: Novartis Pharmaceutical Corporation is currently conducting a 5 week clinical research study for adult males 20 years old and older for the treatment of atopic dermatitis.
The goal of this clinical research study is to determine what changes occur in the skin when the study drug is used to treat eczema (atopic dermatitis).
Participants must meet all of the following criteria:
· Must be a male 20 years old or older,
· Have a diagnosis of atopic dermatitis for at least 3 years, and
· Have a mild to moderate episode of atopic dermatitis within 5 days prior to entering the study.
You CANNOT participate if you:
· Have a history of rheumatic fever, heart valve replacement,
· Have prosthetic joints or other prosthetics (e.g. lens implants, or hip joints),
· History of HIV positive, Hepatitis B or Hepatitis C., or
· Have used corticosteroids (e.g. topical, oral intravenous or rectal) within 4 weeks prior to entering the study.
For additional information about this trial, contact:
Vicky Wong, Study Coordinator
Mount Sinai School of Medicine
5 East 98th Street
New York, NY 10029
Telephone: 212-241-3288
Fax: 212-876-8961
Email: vicky.wong@mssm.edu

Summary: Atopic Dermatitis (Dry, itchy inflamed skin) rough on you?
Radiant Research is conducting a clinical research study of an investigational medication for Atopic Dermatitis. Participants will receive study medication, study-related exams and compensation (up to $150) for time and travel.
Inclusion Criteria:
· Age 18 or older, male and female,
· Atopic dermatitis on the face.
Contact:
Peter Ratcliffe, Participant
Recruitment Specialist
Radiant Research - Columbus
1275 Olentangy River Road, Suite 202
Columbus, OH 43212
Telephone: 614-442-9230
Email: peterratcliffe@radiantresearch.com

Summary: Have you spotted a red, itchy rash on your scalp, arms or legs? It could be...Eczema.
Eczema or Atopic Dermatitis is a skin disease, which usually begins with itching and is followed by a rash. This study is evaluating an investigational medication for Atopic Dermatitis. Participants must be between the ages of 18 and 65 with mild to moderate eczema.
Participants will receive:
· Investigational medication
· Study-related exams
· Compensation $200.00 for time and travel
Call Mon - Fri for more information. Contact:
Christine
Impact Clinical Trials
4311 Wilshire Boulevard
Suite 110
Los Angeles, CA 90010
Telephone: 323-937-7811
Fax: 323-937-7818
Email: trials@impactla.org

To find clinical trials in your area, go to: http://www.centerwatch.com/search.asp